Accurexa Submits its BranchPoint Device to FDA for 510(k) Clearance

June 15, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 15, 2015 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that it has filed a submission with the U.S. Food and Drug Administration (FDA) for 510(k) clearance to market its BranchPoint device. The Company's BranchPoint device was invented to deliver therapeutics, such as stem cells, through the...

Read more

Heliospectra to be a Featured Presenter at the 2015 Major Investment Themes Conference

June 15, 2015 8:00 AM

NEW YORK, NY / ACCESSWIRE / June 15, 2015 / Heliospectra AB (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technologies for plant research and greenhouse cultivation, is pleased to announce that it will be a featured presenter at the 2015 Major Investment Themes Conference in the Legal Cannabis Track. The conference will be held on June 16, 2015 at the historic Harvard Club in New York City. The event is New York's...

Read more

Heliospectra to be a Featured Presenter at the Viridian Cannabis Investor Conference

June 12, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 12, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technologies for plant research and greenhouse cultivation, is pleased to announce that it will be a featured presenter at the Viridian Capital Cannabis Investor Conference, New York City's first cannabis investment seminar. The conference will be held on June 18, 2015 at the Jacob Javits Center in New York...

Read more

True2Beauty's LegacyXChange Becomes Preferred Memorabilia Partner with The National Basketball Retired Players Association

June 11, 2015 9:20 AM

LegacyXChange Hosting Players Penthouse Lounge, Beginning Sign up Process for Retired Athletes in Las Vegas at NBRPA National MeetingBOCA RATON, FL / ACCESSWIRE / June 11, 2015 / True2Beauty, Inc. (OTC Pink: TRTB) (PINKSHEETS: TRTB), the company that plans to launch an online retailing platform through its subsidiary, LegacyXChange, Inc. and the National Basketball Retired Players Association (also known as "NBRPA") are pleased to...

Read more

Heliospectra Rated Best in New Study Carried Out by The University of Akron Research Foundation

June 4, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / June 4, 2015 / (OTCQB: HLSPY, FIRSTNORTH: HELIO), Heliospectra AB (publ), which is a world leader in intelligent lighting technologies for plant research and greenhouse cultivation, gets top score in a new study carried out by the American University of Akron Research Foundation. In the study, Heliospectra's LX60 got the best score out of the light sources tested. The study, which involved lettuce (Lactuca...

Read more

American Cryostem Welcomes Dr. KiBum Lee To Medical & Scientific Advisory Board

June 3, 2015 8:55 AM

EATONTOWN, NJ / ACCESSWIRE / June 3, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the addition of Dr. KiBum Lee to the Medical & Scientific Advisory Board. Dr. KiBum Lee will be assisting CRYO in further developing its adipose ...

Read more

Vitro Biopharma Launches MSC-derived Cardiac and Neural Cells for Pre-clinical Toxicology Testing

June 2, 2015 9:50 AM

GOLDEN, CO / ACCESSWIRE / June 2, 2015 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the commercial launch of cardiac and neural cells that are differentiated from human MSCs. Our new products include cardiomyocytes, alpha motor neurons and neural stem cells. In support of this commercial launch, we have also launched an improved and updated website featuring enhanced functionality and improved access to product...

Read more

Naturally Splendid Launches Bulk Ingredient Division

May 29, 2015 7:43 PM

VANCOUVER, BC / ACCESSWIRE / May 29, 2015 / Naturally Splendid Enterprises Ltd. (the "Company") (FRANKFURT:50N) (TSX VENTURE:NSP) (OTC:NSPDF) is excited to announce the official launch of their new, plant-based bulk division, BCI (also known as BC Ingredients). Many of the ingredients will be manufactured at POS Bio-Sciences in their BPC Facility located in Saskatoon, Saskatchewan. The website for BCI can be found at www.bcingredients.com...

Read more

Unique Cooperation Between Qatar and Sweden Provides Gulf States New Swedish Environmental Technology

May 28, 2015 9:43 AM

SAN FRANCISCO, CA / ACCESSWIRE / May 28, 2015 / Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, is part of a unique agreement between Midroc New Technology and GORD - the Gulf Organisation for Research and Development.New and revolutionary environmental technology from four Swedish companies will be displayed in a special full-scale facility in...

Read more

Arrayit Corporation and Vivos Team Up on Global Genome Vault

May 13, 2015 12:21 PM

SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. Vivos offers an impervious, impenetrable and permanent DNA storage vault, able to provide virtually every man, woman and child on Earth, a safe and secure, nuclear blast-proof, underground...

Read more

Heliospectra AB to Exhibit and Present at the MoneyShow in Las Vegas, Nevada

May 7, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2015 / ​​Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for plant research and greenhouse cultivation, will be speaking and exhibiting at the MoneyShow in Las Vegas, NV. The MoneyShow will be held at Caesar's Palace in Las Vegas from May 11 to May 14. Heliospectra will be exhibiting at Booth #316. Mr. Staffan Hillberg, CEO and co-founder of...

Read more

Vitro Biopharma Expands Capacity to Meet Increased Demand for MSC-Gro(TM) Stem Cell Culture Media

April 29, 2015 9:25 AM

GOLDEN, CO / ACCESSWIRE / April 29, 2015 / Vitro Diagnostics, Inc. (PINKSHEETS: VODG), dba Vitro Biopharma, announced expansion of manufacturing capacity based on a recent orders for bulk quantities of its MSC-Gro(TM) Brand of stem cell growth media. Increased demand comes from sales to stem cell researchers and a new customer who recently qualified our media for use in its clinical testing program. We have received...

Read more

LegacyXChange Signs LOI with YPB Group to Enhance Technology Platform with World Class Anti-Counterfeit Solution

April 29, 2015 9:20 AM

Possible Innovative New Partnership Would Debut with the Launch of an Online Platform for Trading Collectibles and Memorabilia in the First Half of 2015BOCA RATON, FL / ACCESSWIRE / April 29, 2015 / True2Beauty, Inc., (OTC Pink: TRTB) (PINKSHEETS: TRTB), in its continued effort to utilize the best in breed of anti counterfeit technology for its LegacyXChange website to be launched in the second quarter of 2015, has signed a Letter Of...

Read more

American Cryostem Announces Acquisition of Biolife Cell Bank

April 20, 2015 8:30 AM

EATONTOWN, NJ / ACCESSWIRE / April 20, 2015 / American CryoStem Corporation (PINKSHEETS: CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the acquisition of Biolife Cell Bank's (Biolife) adipose tissue and adipose derived stem cell banking services assets. Located in Dallas, Texas, Biolife operated...

Read more

Mymetics-led Consortium Awarded Euro 8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines

April 20, 2015 2:00 AM

- Mymetics virosome vaccine technology and HIV vaccine candidate to be used as basis to develop a scalable manufacturing process within 3.5 years - Funding this project can represent a major innovation in the world of vaccine as more than 90% of the existing vaccines are dependent on the cold-chain EPALINGES, SWITZERLAND / ACCESSWIRE / April 20, 2015 / Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of...

Read more

Accurexa's First "New To The Street" Interview on YouTube

April 6, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / April 6, 2015 / Accurexa Inc. (the "Company") (OTCQB:ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that its first "New To The Street" interview was aired nationwide and is available on YouTube under the following link (https://www.youtube.com/watch?v=7tUYtz7WV2U). In the 10 minute interview, Dr. George Yu, the Company's President &...

Read more

Avagenesis Corp. Completes Acquisition of Curastem Biomedical Corp.

March 18, 2015 2:13 AM

CALGARY, ALBERTA / ACCESSWIRE / March 18, 2015 / Further to its news releases of January 15, 2015, and March 13, 2015, Avagenesis Corp. (TSX VENTURE:VVA) ("Avagenesis" or the "Company") today announced the closing of the transactions contemplated in the share exchange agreement dated as of January 15, 2015 between Avagenesis and Curastem Biomedical Corp., including the closing of a private placement by Curastem for gross proceeds of...

Read more

Avagenesis Corp. Receives TSXV Conditional Approval to the Acquisition of Curastem Biomedical Corp.

March 13, 2015 3:06 PM

CALGARY, AB / ACCESSWIRE / March 13, 2015 / Further to its news release dated January 15, 2015, Avagenesis Corp. (TSXV: VVA) ("Avagenesis" or the "Company") has received conditional approval from the TSX Venture Exchange ("TSXV") of the proposed share exchange transaction with Curastem Biomedical Corp. ("Curastem"). The share exchange transaction is expected to close on Monday, March 16, 2015, pursuant to which the Company will issue 1,580,821...

Read more

Baby Boomers Spend Billions to Stay Young

March 9, 2015 9:32 AM

Abattis Bioceuticals Signs $25 Million Deal with Dutchess Fund VANCOUVER, BC / ACCESSWIRE / March 9, 2015 / According to New York based Transparency Market Research the global nutraceuticals market will reach $204 billion by 2017 - fueled by health obsessed baby-boomers - who still ski and play competitive sports into their 60s and 70s. Abattis Bioceuticals (ATT-CSE) (ATTBF-OTCQX) is a vertically integrated nutraceuticals company...

Read more

Accurexa's Licensed Patent Application Enters National Phase

March 9, 2015 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / March 9, 2015 / Accurexa Inc. (the "Company") (OTCQB:ACXA), a biotechnology company focused on developing and commercializing novel neurological therapies, announced today that the U.S. Patent Application No. PCT/US2013/052301, Microinjection Catheter; UC Case No. SF2012-063, which the Company exclusively licensed from the University of California, San Francisco (UCSF), has entered national phase applications...

Read more